Last edition
News about "biosimilar drug products "
Biocon Signs Exclusive Licensing and Supply Deal with Biomm for Drug Commercialization
Biocon Limited has signed an exclusive licensing and supply agreement with Biomm to commercialize its vertically integrated drug product, Semaglutide (gOzempic).
Biosimilar Drug Products | 19/04/2024 | By Aishwarya | 103
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members